The A2Z Market Research report on “Global Gene-based Therapy Medicinal Market Report 2024 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030” offers strategic visions into the global Gene-based Therapy Medicinal market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2024 to 2030. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Gene-based Therapy Medicinal product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2024 to 2030. The study highlights current market trends for Gene-based Therapy Medicinal and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Gene-based Therapy Medicinal market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Gene-based Therapy Medicinal market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2030 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Gene-based Therapy Medicinal market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Gene-based Therapy Medicinal market are:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segmentation by Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
Market segmentation by Application:
Neurological Diseases
Cancer
Other
Table of Content
Global Gene-based Therapy Medicinal Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030
Chapter 1 Gene-based Therapy Medicinal Market Overview
1.1 Product Overview and Scope of Gene-based Therapy Medicinal
1.2 Gene-based Therapy Medicinal Market Segmentation by Type
1.2.1 Global Production Market Share of Gene-based Therapy Medicinal by Type in 2024
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Gene-based Therapy Medicinal Market Segmentation by Application
1.3.1 Gene-based Therapy Medicinal Consumption Market Share by Application in 2024
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Gene-based Therapy Medicinal Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Gene-based Therapy Medicinal (2018-2030)
Chapter 2 Global Economic Impact on Gene-based Therapy Medicinal Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Gene-based Therapy Medicinal Market Competition by Manufacturers
3.1 Global Gene-based Therapy Medicinal Production and Share by Manufacturers (2024 and 2024)
3.2 Global Gene-based Therapy Medicinal Revenue and Share by Manufacturers (2024 and 2024)
3.3 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2024 and 2024)
3.4 Manufacturers Gene-based Therapy Medicinal Manufacturing Base Distribution, Production Area and Product Type
3.5 Gene-based Therapy Medicinal Market Competitive Situation and Trends
3.5.1 Gene-based Therapy Medicinal Market Concentration Rate
3.5.2 Gene-based Therapy Medicinal Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Gene-based Therapy Medicinal Production, Revenue (Value) by Region (2018-2024)
4.1 Global Gene-based Therapy Medicinal Production by Region (2018-2024)
4.2 Global Gene-based Therapy Medicinal Production Market Share by Region (2018-2024)
4.3 Global Gene-based Therapy Medicinal Revenue (Value) and Market Share by Region (2018-2024)
4.4 Global Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.5 North America Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.6 Europe Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.7 China Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.8 Japan Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.9 Southeast Asia Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
4.10 India Gene-based Therapy Medicinal Production, Revenue, Price and Gross Margin (2018-2024)
Chapter 5 Global Gene-based Therapy Medicinal Supply (Production), Consumption, Export, Import by Regions (2018-2024)
5.1 Global Gene-based Therapy Medicinal Consumption by Regions (2018-2024)
5.2 North America Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
5.3 Europe Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
5.4 China Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
5.5 Japan Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
5.6 Southeast Asia Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
5.7 India Gene-based Therapy Medicinal Production, Consumption, Export, Import by Regions (2018-2024)
Chapter 6 Global Gene-based Therapy Medicinal Production, Revenue (Value), Price Trend by Type
6.1 Global Gene-based Therapy Medicinal Production and Market Share by Type (2018-2024)
6.2 Global Gene-based Therapy Medicinal Revenue and Market Share by Type (2018-2024)
6.3 Global Gene-based Therapy Medicinal Price by Type (2018-2024)
6.4 Global Gene-based Therapy Medicinal Production Growth by Type (2018-2024)
Chapter 7 Global Gene-based Therapy Medicinal Market Analysis by Application
7.1 Global Gene-based Therapy Medicinal Consumption and Market Share by Application (2018-2024)
7.2 Global Gene-based Therapy Medicinal Consumption Growth Rate by Application (2018-2024)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Gene-based Therapy Medicinal Manufacturing Cost Analysis
8.1 Gene-based Therapy Medicinal Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gene-based Therapy Medicinal
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gene-based Therapy Medicinal Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gene-based Therapy Medicinal Major Manufacturers in 2024
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Gene-based Therapy Medicinal Market Forecast (2024-2030)
12.1 Global Gene-based Therapy Medicinal Production, Revenue Forecast (2024-2030)
12.2 Global Gene-based Therapy Medicinal Production, Consumption Forecast by Regions (2024-2030)
12.3 Global Gene-based Therapy Medicinal Production Forecast by Type (2024-2030)
12.4 Global Gene-based Therapy Medicinal Consumption Forecast by Application (2024-2030)
12.5 Gene-based Therapy Medicinal Price Forecast (2024-2030)
Chapter 13 Appendix